163 related articles for article (PubMed ID: 12956898)
1. Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits.
Doki K; Hayakawa T; Lin W; Yanaguimoto H; Ding G; Inotsume N
J Pharm Pharmacol; 2003 Aug; 55(8):1091-7. PubMed ID: 12956898
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ibuprofen enantiomers in dogs.
Beck WS; Geisslinger G; Engler H; Brune K
Chirality; 1991; 3(3):165-9. PubMed ID: 1911048
[TBL] [Abstract][Full Text] [Related]
3. Evidence of absorption rate dependency of ibuprofen inversion in the rat.
Sattari S; Jamali F
Chirality; 1994; 6(5):435-9. PubMed ID: 8068501
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction of ibuprofen enantiomers in rabbits.
Lin W; Hayakawa T; Yanaguimoto H; Kuzuba M; Obara T; Ding G; Cui F; Inotsume N
J Pharm Pharmacol; 2004 Mar; 56(3):317-21. PubMed ID: 15025856
[TBL] [Abstract][Full Text] [Related]
5. Effect of absorption rate on pharmacokinetics of ibuprofen in relation to chiral inversion in humans.
Ding G; Liu Y; Sun J; Takeuchi Y; Toda T; Hayakawa T; Fukushima S; Kishimoto S; Lin W; Inotsume N
J Pharm Pharmacol; 2007 Nov; 59(11):1509-13. PubMed ID: 17976261
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
[TBL] [Abstract][Full Text] [Related]
7. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
Janjikhel RK; Adeyeye CM
J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
[TBL] [Abstract][Full Text] [Related]
8. Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individuals.
Siemon D; de Vries JX; Stötzer F; Walter-Sack I; Dietl R
Eur J Med Res; 1997 May; 2(5):215-9. PubMed ID: 9153347
[TBL] [Abstract][Full Text] [Related]
9. Topical administration of racemic ibuprofen.
Millership JS; Collier PS
Chirality; 1997; 9(3):313-6. PubMed ID: 9176998
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
11. Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.
Walser S; Hruby R; Hesse E; Heinzl H; Mascher H
Arzneimittelforschung; 1997 Jun; 47(6):750-4. PubMed ID: 9239454
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding.
Itoh T; Maruyama J; Tsuda Y; Yamada H
Chirality; 1997; 9(4):354-61. PubMed ID: 9275314
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ibuprofen enantiomers in rats after intravenous and oral administration of ibuprofen arginate.
Wang XL; Han J; Zhang D; Liu HC
Yao Xue Xue Bao; 2012 Jan; 47(1):88-93. PubMed ID: 22493811
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective disposition of tiaprofenic acid enantiomers in rats.
Erb K; Brugger R; Williams K; Geisslinger G
Chirality; 1999; 11(2):103-8. PubMed ID: 9951401
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective systemic disposition of ibuprofen enantiomers in the dog.
Ahn HY; Amidon GL; Smith DE
Pharm Res; 1991 Sep; 8(9):1186-90. PubMed ID: 1788165
[TBL] [Abstract][Full Text] [Related]
16. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration.
Kyllönen M; Olkkola KT; Seppälä T; Ryhänen P
Paediatr Anaesth; 2005 Jul; 15(7):566-73. PubMed ID: 15960640
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of ibuprofen bioinversion by simulation.
Romero AJ; Rackley RJ; Rhodes CT
Chirality; 1991; 3(5):418-21. PubMed ID: 1756097
[TBL] [Abstract][Full Text] [Related]
18. Impaired intrinsic chiral inversion activity of ibuprofen in rats with adjuvant-induced arthritis.
Uno S; Uraki M; Komura H; Ikuta H; Kawase A; Iwaki M
Xenobiotica; 2008 Nov; 38(11):1410-21. PubMed ID: 18988084
[TBL] [Abstract][Full Text] [Related]
19. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration.
Kimura S; Imai T; Otagiri M
Pharm Acta Helv; 1991; 66(4):120-4. PubMed ID: 1758897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
